PX'Therapeutics

GMP Manufacturing Services

PX’Therapeutics offers process scale up, preclinical and GMP manufacturing services for protein, antibody or vaccine candidates. 

For early stage projects, we can support all the discovery and process development steps before initiating GMP clinical manufacturing campaigns (see Protein R&D). 

For mature projects, we operate process transfer and provide manufacturing slots with limited reservation fees as our policy is to offer high degrees of flexibility to our clients.

Our small scale GMP production facilities (400m² excluding Analytical lab) are perfectly suitable for the supply of biological material for preclinical studies, phase I/II clinical trials. Manufacturing scales are specifically relevant for the production of original biotherapeutics and vaccines /recombinant antigens.
Is this your Organization?   Request Access

Locations


France
PX’Therapeutics – Headquarters
BHT - 7, Parvis Louis Néel
CS 20050
GRENOBLE CEDEX 9,   38040
France, Europe

Contacts


Claire Untereiner
Chief Operating Officer
Christelle Belkadhi
Business Development Assistant

Production Lines

PX’Therapeutics – Headquarters   GMP Microbial Production Facilities
Location: GRENOBLE CEDEX 9, France
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  MicrobialMicrobial
BioReactor Process:  Fed-BatchFed-Batch
BioReactor Scale:  1L-100L50L Bioreactor
GMP Level:  Phase I/IIPhase I/II
Biosafety Level:  Not SpecifiedNot Specified
Single Use:  AllAll
Additional Services
Analytical Services are Not AvailableAnalytical Services
Cell Banking is Not AvailableCell Banking
Cell Line Development is Not AvailableCell Line Development
Preclinical Manufacturing is Not AvailablePreclinical Manufacturing
Viral Manufacturing is Not AvailableViral Manufacturing
Availability: Contact CMO

Last Update: 23MAY17

Send Inquiry about this Production Line
PX’Therapeutics – Headquarters   GMP Mammalian Cell Culture Production Facilities
Location: GRENOBLE CEDEX 9, France
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  Cell CultureCell Culture
BioReactor Process:  Fed-BatchFed-Batch
BioReactor Scale:  100L-2000L250L Bioreactor
GMP Level:  Phase I/IIPhase I/II
Biosafety Level:  Not SpecifiedNot Specified
Single Use:  AllAll
Additional Services
Analytical Services are Not AvailableAnalytical Services
Cell Banking is Not AvailableCell Banking
Cell Line Development is Not AvailableCell Line Development
Preclinical Manufacturing is Not AvailablePreclinical Manufacturing
Viral Manufacturing is Not AvailableViral Manufacturing
Availability: Contact CMO

Last Update: 23MAY17

Send Inquiry about this Production Line

Copyright © Kymanox, All Rights Reserved.